查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2018762

神經外科電動手術器械市場：按產品類型、動力來源、應用和最終用戶分類－2026-2032年全球市場預測

Neurosurgery Surgical Power Tools Market by Product Type, Power Source, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 198 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，神經外科電動手術器械的市場價值將達到 19.6 億美元，到 2026 年將成長到 21.1 億美元，到 2032 年將達到 33.6 億美元，複合年成長率為 8.01%。

主要市場統計數據
基準年 2025 19.6億美元
預計年份：2026年 21.1億美元
預測年份 2032 33.6億美元
複合年成長率 (%) 8.01%

這篇權威概述說明了臨床需求、醫療設備技術的進步以及醫療機構的採購重點如何改變電動神經外科器械的採用情況。

隨著人體工學、精密工程和工作流程整合在醫療設備的融合，術中能力不斷重塑，神經外科實務正步入持續改善的階段。外科醫生日益要求器械具備一致的觸覺回饋、更低的熱負荷以及與導航和視覺化平台的模組化相容性。同時，醫院管理者優先考慮那些能夠支援消毒和維護工作流程的器械，以縮短手術時間、簡化器械庫存並降低整體擁有成本。這些相互交織的臨床和營運壓力正在重塑整個醫療機構的採購標準和臨床應用路徑。

微創技術、數位整合、供應鏈韌性和監管如何從根本上改變產品預期和競爭定位。

近年來，神經外科手術用電動器材領域發生了翻天覆地的變化，正在改變競爭動態和商業機會。首先，微創手術方式的興起，使得對小型化、低振動器械的需求日益成長，這類器械能夠在精準切除骨骼的同時，最大限度地減少對周圍組織的影響。這種轉變促使數位化導航系統的應用日益廣泛，這要求器械在設計階段就具備導航功能，或能夠輕鬆適應現有平台。因此，器材工程師與導航軟體團隊之間的協作已成為競爭格局中的關鍵差異化因素。

關稅制度變化對神經外科醫療設備製造商和醫院的籌資策略、供應商多元化和採購安全措施的實際影響。

貿易政策和關稅框架的變化給神經外科手術用電動器械供應商帶來了新的營運和採購考量。影響零件、子組件和成品的關稅調整，使得企業更加關注近岸外包、供應商多元化和總到岸成本分析。隨著企業重新評估供應商合約和製造地，採購團隊優先考慮具有本地生產能力和完善品管系統的替代供應商，以降低跨境關稅和運輸延誤的風險。

將醫療設備分類、臨床應用、終端使用者採購模式和電源需求連結起來的詳細細分分析，可以完善產品和市場進入策略。

了解細分市場的細微差別對於制定有針對性的產品策略和商業化計劃至關重要。按產品類型分類，市場可分為鑽頭、電鑽、螺絲起子和鋸片，每類產品都有其獨特的設計、消毒和耐用性要求，這些要求會影響採購決策。按應用領域分類，臨床重點領域包括開顱手術、脊椎手術、創傷和腫瘤切除術，手術入路、手術通道限制以及與術中影像的兼容性對醫療設備的選擇有顯著影響。依最終使用者分類，採購環境涵蓋門診手術中心、醫院和專科診所。門診手術中心可分為醫院附設門診及獨立門診，醫院分為私立醫院及公立醫院，專科診所分為全科診所和神經外科中心。所有這些都導致​​了不同的採購週期和資本投資核准流程。按電源類型分類，電池供電和有線設備之間的差異會影響消毒、電池生命週期管理和手術室配置等方面的考慮。

美洲、歐洲、中東和非洲以及亞太地區在管理體制、報銷趨勢和臨床基礎設施方面的地域差異，會對商業化和支持模式產生怎樣的影響？

區域趨勢對神經外科電動器械的採用途徑、監管合規性和分銷策略有顯著影響。在美洲，醫院網路和門診中心往往優先考慮採購速度和與分銷合作夥伴的直接關係，而報銷機制和醫療採購集團則主導著器械的採用模式。監管途徑和上市後監測要求因司法管轄區而異，因此製造商需要相應地調整標籤、臨床證據包和支持系統。

決定供應商選擇和長期臨床實施的關鍵競爭差異化因素包括技術性能、臨床醫生培訓計劃和卓越的服務。

神經外科電動器材領域競爭日益激烈，其驅動力源自於技術差異化、服務模式以及展現以臨床醫生為中心的療效的能力。主要企業正致力於降低器械振動、改進人體工學設計，並確保與導航和成像系統相容，以滿足外科醫生的期望。售後服務體驗同樣至關重要。可靠的技術服務、穩定的耗材供應以及透明的維修和翻新流程，都對供應商的長期合作關係產生影響。

製造商和醫院採購經理應立即採取策略措施，以協調產品開發、證據產生和供應彈性，以實現永續的臨床部署。

產業領導企業可以透過實施一系列切實可行的措施來加速成長和臨床應用，這些措施將工程重點與採購實際情況相結合。首先，優先考慮能夠解決臨床醫生透過結構化外科醫師回饋所記錄的挑戰的產品設計，重點在於人體工學、振動控制和導航相容性。其次，開發結合技術台架測試和實際應用研究的證據包，以證明產品在典型臨床環境中的安全性和操作效率。第三，投資於能夠反映不同採購計畫的靈活商業模式，包括獨立門診中心、私人醫院和公立醫院系統，並確保提供租賃、寄售和耗材捆綁等選項。

嚴謹、多方面的研究途徑，結合對臨床醫生的訪談、對監管和臨床文獻的審查以及對醫療設備的技術評估，確保了可靠、可操作的見解。

本研究整合了多方面研究成果，包括與臨床醫生和採購相關人員的直接訪談、對監管指南和臨床文獻的二次研究，以及對器械設計特性的技術評估。主要資訊來源包括與執業神經外科醫生、手術室護理長和醫院供應鏈經理的結構化訪談和諮詢會議，以了解臨床重點、器械操作回饋和採購限制。二級資訊來源包括同儕審查的外科手術文獻、醫療設備監管申報文件和產業白皮書，以驗證醫療設備技術特性與已記錄的臨床結果和安全性數據是否一致。

簡單總結指出，臨床療效、融入營運以及供應鏈韌性這三者結合起來，是永續採用電動神經外科器械解決方案的關鍵因素。

目前，神經外科手術用電動器械的發展現狀是臨床性能要求、操作限制和監管預期之間複雜相互作用的結果。無線技術的進步、符合人體工學設計的改進以及與導航系統的緊密整合，顯著提升了術中效率和外科醫生的操控性。同時，採購團隊也越來越關注消毒流程、服務可靠性以及器械組合對整體成本的更廣泛影響。這些因素共同作用，使得那些能夠將成熟的臨床價值、穩健的供應模式和全面的售後服務支援相結合的公司更具優勢。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章：神經外科電外科器械市場：依產品類型分類

  • 酒吧
  • 鑽頭
  • 促進要素
  • 鋸

第9章：電動神經外科器械市場：依動力來源

  • 電池供電
  • 有線型

第10章：電動神經外科器械市場：依應用領域分類

  • 開顱手術
  • 脊椎手術
  • 創傷
  • 腫瘤切除

第11章：神經外科電外科器械市場：依最終用戶分類

  • 門診手術中心
  • 醫院
  • 專科診所

第12章：神經外科電外科器械市場：依地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第13章：神經外科電動手術器械市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章：電動神經外科器械市場：按國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章：美國電動神經外科器械市場

第16章：中國電動神經外科器械市場

第17章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Arthrex, Inc.
  • B. Braun Melsungen AG
  • CONMED Corporation
  • Globus Medical, Inc.
  • Integra LifeSciences Holdings Corporation
  • Johnson & Johnson
  • Karl Storz SE & Co. KG
  • Leica Microsystems
  • Medtronic plc
  • NuVasive, Inc.
  • Olympus Corporation
  • Richard Wolf GmbH
  • Smith & Nephew plc
  • Stryker Corporation
  • Wright Medical Group NV
  • Zimmer Biomet Holdings, Inc.
Product Code: MRR-A26E0E57439B

The Neurosurgery Surgical Power Tools Market was valued at USD 1.96 billion in 2025 and is projected to grow to USD 2.11 billion in 2026, with a CAGR of 8.01%, reaching USD 3.36 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 1.96 billion
Estimated Year [2026] USD 2.11 billion
Forecast Year [2032] USD 3.36 billion
CAGR (%) 8.01%

An authoritative overview explaining how clinical demands, device engineering advances, and institutional procurement priorities are reshaping neurosurgical power tool adoption

Neurosurgical practice is undergoing a period of sustained refinement as device ergonomics, precision engineering, and workflow integration converge to redefine intraoperative capability. Surgeons are increasingly demanding instruments that deliver consistent tactile feedback, reduced thermal footprint, and modular compatibility with navigation and visualization platforms. Concurrently, hospital administrators prioritize devices that shorten procedure time, minimize instrument inventory complexity, and support sterilization and maintenance workflows that reduce total cost of ownership. These intersecting clinical and operational pressures are reshaping procurement criteria and clinical adoption pathways across institutions.

Moreover, regulatory emphasis on device safety, post-market surveillance, and reusable-versus-single-use lifecycle assessments is prompting manufacturers to refine design controls and quality systems. Innovations in battery technology, cordless mechanics, and acoustic telemetry are enabling new form factors that improve OR ergonomics and mobility without compromising power delivery. As a result, companies that align product development with documented clinician pain points, validated safety improvements, and streamlined supply chain logistics are best positioned to influence purchasing committees and clinician champions. In short, understanding the interplay between clinical needs, device engineering, and institutional procurement priorities is essential to developing a defensible strategy in this evolving landscape.

How minimally invasive techniques, digital integration, supply chain resilience, and regulatory scrutiny are fundamentally changing product expectations and competitive positioning

Over the last several years, transformative shifts have emerged that alter competitive dynamics and opportunity windows within neurosurgical power tools. First, the migration toward minimally invasive approaches has heightened the premium on compact, low-vibration instruments that provide precise bone removal with minimized collateral tissue impact. This shift is accompanied by greater integration of digital guidance systems, which requires tools that are either navigation-compatible by design or easily adapted to existing platforms. As a result, collaboration between device engineers and navigation software teams has become a competitive differentiator.

Second, supply chain resilience and sterilization efficiency now play a more visible role in formulary decisions. Hospitals are placing a higher value on devices that reduce instrument turnover time and simplify maintenance workflows. Third, innovations in battery chemistry and cordless motor design have accelerated acceptance of untethered tools in both the operating room and ambulatory settings, enabling greater flexibility in procedure scheduling and room utilization. Finally, reimbursement and regulatory scrutiny of device reprocessing and safety are driving companies to provide robust evidence packages and post-market surveillance commitments. Together, these shifts favor vendors that can demonstrate demonstrable clinical benefit, operational savings, and regulatory transparency.

Practical implications of changing tariff regimes on sourcing strategies, supplier diversification, and procurement safeguards for neurosurgical device manufacturers and hospitals

Changes in trade policy and tariff frameworks have introduced new operational and sourcing considerations for companies supplying neurosurgical power tools. Tariff adjustments affecting components, subassemblies, and finished devices have increased attention to nearshoring, supplier diversification, and total landed cost analysis. As companies reassess vendor contracts and manufacturing footprints, procurement teams are prioritizing alternative suppliers with localized production capabilities and robust quality management systems to mitigate exposure to cross-border duties and shipment delays.

Consequently, strategic sourcing initiatives now emphasize dual-sourcing of critical components, greater inventory visibility, and scenario planning for customs and compliance contingencies. Manufacturers are also reevaluating their bill of materials to identify components subject to higher duty classifications and seeking engineering substitutions where clinically acceptable. In tandem, contract negotiations with hospital systems increasingly include clauses that address potential price volatility stemming from external trade actions. For clinical leaders and procurement directors, translating tariff-related operational risk into procurement safeguards and supplier scorecards has become an essential adjunct to traditional value-based assessment processes.

Detailed segmentation analysis linking device classes, clinical applications, end-user procurement archetypes, and power source implications to refine product and go-to-market strategies

Understanding segmentation nuance is essential to developing targeted product strategies and commercialization plans. Based on Product Type, the landscape is delineated across Burrs, Drills, Drivers, and Saws, and each category presents distinct engineering, sterilization, and endurance requirements that shape procurement conversations. Based on Application, clinical focus areas include Craniotomy, Spinal Surgery, Trauma, and Tumor Resection, where surgical approach, access constraints, and intraoperative imaging compatibility materially influence device selection. Based on End User, the purchasing environment spans Ambulatory Surgical Center, Hospitals, and Specialty Clinics, with the Ambulatory Surgical Center further differentiated into Hospital Affiliated and Independent, Hospitals further classified into Private Hospital and Public Hospital, and Specialty Clinics segmented into Multi Specialty Clinic and Neurosurgery Center, all of which create divergent procurement cycles and capital approval pathways. Based on Power Source, distinctions between Battery Powered and Wired tools inform considerations around sterilization, battery lifecycle management, and OR setup preferences.

These segmentation dimensions interact: for example, ambulatory settings-especially independent centers-often prefer battery powered, compact drills and drivers that minimize room turnover, whereas large public hospitals managing complex tumor resections may prioritize high-torque wired saws and drills with demonstrated compatibility with intraoperative imaging. Similarly, product type influences maintenance protocols and consumable frameworks; burrs and saw blades necessitate distinct reprocessing and replacement cadences that directly affect cost of ownership conversations. By mapping product design and evidence generation to the specific clinical application and procurement archetype, organizations can craft differentiated value propositions that resonate with both surgeon end users and hospital procurement committees.

How geographic regulatory regimes, reimbursement dynamics, and clinical infrastructure differences across the Americas, Europe Middle East & Africa, and Asia-Pacific shape commercialization and support models

Regional dynamics materially affect adoption pathways, regulatory compliance, and distribution strategy for neurosurgical power tools. In the Americas, hospital networks and ambulatory centers often emphasize time-to-procurement and direct relationships with distributor partners, with reimbursement frameworks and institutional purchasing groups driving adoption patterns. Regulatory pathways and post-market surveillance obligations vary by jurisdiction, prompting manufacturers to tailor labeling, clinical evidence packages, and support infrastructure accordingly.

In Europe, Middle East & Africa, diverse regulatory environments and uneven hospital infrastructure necessitate flexible commercial models and tiered service offerings. Strategic partnerships with regional distributors and localized training programs can accelerate adoption in markets where capital cycles and procurement processes differ from metropolitan centers. Meanwhile, in Asia-Pacific, rapid infrastructure investment in tertiary referral centers and a growing number of specialty neurosurgery clinics are creating demand for both high-performance wired systems and portable battery powered tools that suit mixed practice settings. Across all regions, the ability to provide robust clinician training, responsive technical service, and compliant documentation is a prerequisite for sustainable in-market performance. Therefore, companies must adapt regional go-to-market plans to reflect regulatory nuances, reimbursement realities, and the prevailing clinical infrastructure in each geography.

Key competitive differentiators including engineering performance, clinician training programs, and service excellence that determine supplier preference and long-term clinical adoption

Competitive intensity in neurosurgical power tools is driven by engineering differentiation, service models, and the ability to demonstrate clinician-centered outcomes. Leading companies focus on reducing device vibration, improving ergonomics, and ensuring compatibility with navigation and imaging systems to meet surgeon expectations. Equally important is the aftermarket experience: reliable technical service, predictable supply of consumables, and transparent repair and refurbishment pathways influence long-term supplier relationships.

Strategic partnerships with clinical centers of excellence and active engagement in surgeon advisory panels help companies accelerate design validation and create clinician advocates. In addition, firms that invest in training infrastructure and multi-channel support-combining on-site education with digital learning platforms-are more successful at driving consistent device utilization. Supply chain robustness also differentiates market leaders; firms that maintain geographically distributed manufacturing and rigorous supplier quality programs can better withstand disruptions and support just-in-time delivery models. Finally, transparent post-market surveillance reporting and collaborative evidence generation with academic institutions reinforce trust among hospital procurement committees and clinical champions.

Immediate strategic actions manufacturers and hospital procurement leaders should adopt to align product development, evidence generation, and supply resilience for sustained clinical adoption

Industry leaders can accelerate growth and clinical acceptance by executing a set of pragmatic actions that align engineering priorities with procurement realities. First, prioritize product designs that address clinician pain points documented through structured surgeon feedback, emphasizing ergonomics, vibration control, and navigation compatibility. Second, develop evidence packages that pair technical bench testing with real-world usability studies to demonstrate safety and operational efficiency in representative clinical settings. Third, invest in flexible commercial models that reflect the heterogeneous procurement timelines of independent ambulatory centers, private hospitals, and public hospital systems, ensuring that leasing, consignment, and bundled consumable options are available.

In parallel, strengthen supply chain resilience by qualifying alternative suppliers for critical components, implementing rigorous supplier audits, and exploring localized assembly or nearshoring options where tariffs or logistics risk are elevated. Expand surgeon education through a blend of on-site mentorship, simulation-based training, and digital modules to shorten the learning curve and embed clinical champions. Finally, formalize post-market surveillance and customer feedback loops to iterate on design improvements and reduce service-related friction, thereby improving long-term device uptime and customer satisfaction.

A rigorous multi-method research approach combining clinician interviews, regulatory and clinical literature review, and technical device evaluations to ensure robust and actionable insights

This research synthesizes insights from a multi-method approach that incorporates primary engagement with clinicians and procurement stakeholders, secondary analysis of regulatory guidance and clinical literature, and technical evaluation of device design attributes. Primary input included structured interviews and advisory sessions with practicing neurosurgeons, OR nursing leadership, and hospital supply chain managers to capture real-world priorities, device handling feedback, and procurement constraints. Secondary sources consisted of peer-reviewed surgical technique literature, device regulatory filings, and industry white papers to align device technical characteristics with documented clinical outcomes and safety profiles.

Technical assessment included comparative review of device ergonomics, power delivery characteristics, and sterilization compatibility based on manufacturer documentation and publicly available technical specifications. Data synthesis emphasized triangulation across sources to validate thematic findings and identify patterns relevant to device design, clinical workflow integration, and procurement behavior. The methodology prioritized transparency in inclusion criteria, documented interview protocols, and an evidence hierarchy to ensure that recommendations reflect both clinical reality and engineering feasibility.

A concise synthesis emphasizing that clinical efficacy, operational integration, and supply chain resilience together determine durable adoption of neurosurgical power tool solutions

The neurosurgical power tools landscape presents a complex interplay of clinical performance demands, operational constraints, and regulatory expectations. Advancements in cordless technology, improved ergonomic design, and tighter integration with navigation systems are creating meaningful benefits in intraoperative efficiency and surgeon control. At the same time, procurement teams are increasingly focused on sterilization workflows, service reliability, and the broader total cost implications of device fleets. These convergent forces favor companies that can combine demonstrable clinical value with resilient supply models and comprehensive post-sale support.

Moving forward, success will depend on the ability to translate surgeon-driven design priorities into scalable manufacturing and distribution strategies while maintaining regulatory compliance and rigorous post-market vigilance. Organizations that foster close collaboration between engineering, clinical affairs, and commercial teams will be best positioned to respond to evolving procedural techniques and institutional purchasing behaviours. Ultimately, a balanced focus on clinician outcomes, operational integration, and supply chain robustness will determine which solutions achieve durable adoption in neurosurgical practice.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Neurosurgery Surgical Power Tools Market, by Product Type

  • 8.1. Burrs
  • 8.2. Drills
  • 8.3. Drivers
  • 8.4. Saws

9. Neurosurgery Surgical Power Tools Market, by Power Source

  • 9.1. Battery Powered
  • 9.2. Wired

10. Neurosurgery Surgical Power Tools Market, by Application

  • 10.1. Craniotomy
  • 10.2. Spinal Surgery
  • 10.3. Trauma
  • 10.4. Tumor Resection

11. Neurosurgery Surgical Power Tools Market, by End User

  • 11.1. Ambulatory Surgical Center
  • 11.2. Hospitals
  • 11.3. Specialty Clinics

12. Neurosurgery Surgical Power Tools Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Neurosurgery Surgical Power Tools Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Neurosurgery Surgical Power Tools Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Neurosurgery Surgical Power Tools Market

16. China Neurosurgery Surgical Power Tools Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. Arthrex, Inc.
  • 17.6. B. Braun Melsungen AG
  • 17.7. CONMED Corporation
  • 17.8. Globus Medical, Inc.
  • 17.9. Integra LifeSciences Holdings Corporation
  • 17.10. Johnson & Johnson
  • 17.11. Karl Storz SE & Co. KG
  • 17.12. Leica Microsystems
  • 17.13. Medtronic plc
  • 17.14. NuVasive, Inc.
  • 17.15. Olympus Corporation
  • 17.16. Richard Wolf GmbH
  • 17.17. Smith & Nephew plc
  • 17.18. Stryker Corporation
  • 17.19. Wright Medical Group N.V.
  • 17.20. Zimmer Biomet Holdings, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL NEUROSURGERY SURGICAL POWER TOOLS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL NEUROSURGERY SURGICAL POWER TOOLS MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL NEUROSURGERY SURGICAL POWER TOOLS MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL NEUROSURGERY SURGICAL POWER TOOLS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL NEUROSURGERY SURGICAL POWER TOOLS MARKET SIZE, BY POWER SOURCE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL NEUROSURGERY SURGICAL POWER TOOLS MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL NEUROSURGERY SURGICAL POWER TOOLS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL NEUROSURGERY SURGICAL POWER TOOLS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL NEUROSURGERY SURGICAL POWER TOOLS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL NEUROSURGERY SURGICAL POWER TOOLS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES NEUROSURGERY SURGICAL POWER TOOLS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA NEUROSURGERY SURGICAL POWER TOOLS MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL NEUROSURGERY SURGICAL POWER TOOLS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL NEUROSURGERY SURGICAL POWER TOOLS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL NEUROSURGERY SURGICAL POWER TOOLS MARKET SIZE, BY BURRS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL NEUROSURGERY SURGICAL POWER TOOLS MARKET SIZE, BY BURRS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL NEUROSURGERY SURGICAL POWER TOOLS MARKET SIZE, BY BURRS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL NEUROSURGERY SURGICAL POWER TOOLS MARKET SIZE, BY DRILLS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL NEUROSURGERY SURGICAL POWER TOOLS MARKET SIZE, BY DRILLS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL NEUROSURGERY SURGICAL POWER TOOLS MARKET SIZE, BY DRILLS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL NEUROSURGERY SURGICAL POWER TOOLS MARKET SIZE, BY DRIVERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL NEUROSURGERY SURGICAL POWER TOOLS MARKET SIZE, BY DRIVERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL NEUROSURGERY SURGICAL POWER TOOLS MARKET SIZE, BY DRIVERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL NEUROSURGERY SURGICAL POWER TOOLS MARKET SIZE, BY SAWS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL NEUROSURGERY SURGICAL POWER TOOLS MARKET SIZE, BY SAWS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL NEUROSURGERY SURGICAL POWER TOOLS MARKET SIZE, BY SAWS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL NEUROSURGERY SURGICAL POWER TOOLS MARKET SIZE, BY POWER SOURCE, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL NEUROSURGERY SURGICAL POWER TOOLS MARKET SIZE, BY BATTERY POWERED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL NEUROSURGERY SURGICAL POWER TOOLS MARKET SIZE, BY BATTERY POWERED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL NEUROSURGERY SURGICAL POWER TOOLS MARKET SIZE, BY BATTERY POWERED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL NEUROSURGERY SURGICAL POWER TOOLS MARKET SIZE, BY WIRED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL NEUROSURGERY SURGICAL POWER TOOLS MARKET SIZE, BY WIRED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL NEUROSURGERY SURGICAL POWER TOOLS MARKET SIZE, BY WIRED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL NEUROSURGERY SURGICAL POWER TOOLS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL NEUROSURGERY SURGICAL POWER TOOLS MARKET SIZE, BY CRANIOTOMY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL NEUROSURGERY SURGICAL POWER TOOLS MARKET SIZE, BY CRANIOTOMY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL NEUROSURGERY SURGICAL POWER TOOLS MARKET SIZE, BY CRANIOTOMY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL NEUROSURGERY SURGICAL POWER TOOLS MARKET SIZE, BY SPINAL SURGERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL NEUROSURGERY SURGICAL POWER TOOLS MARKET SIZE, BY SPINAL SURGERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL NEUROSURGERY SURGICAL POWER TOOLS MARKET SIZE, BY SPINAL SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL NEUROSURGERY SURGICAL POWER TOOLS MARKET SIZE, BY TRAUMA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL NEUROSURGERY SURGICAL POWER TOOLS MARKET SIZE, BY TRAUMA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL NEUROSURGERY SURGICAL POWER TOOLS MARKET SIZE, BY TRAUMA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL NEUROSURGERY SURGICAL POWER TOOLS MARKET SIZE, BY TUMOR RESECTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL NEUROSURGERY SURGICAL POWER TOOLS MARKET SIZE, BY TUMOR RESECTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL NEUROSURGERY SURGICAL POWER TOOLS MARKET SIZE, BY TUMOR RESECTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL NEUROSURGERY SURGICAL POWER TOOLS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL NEUROSURGERY SURGICAL POWER TOOLS MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL NEUROSURGERY SURGICAL POWER TOOLS MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL NEUROSURGERY SURGICAL POWER TOOLS MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL NEUROSURGERY SURGICAL POWER TOOLS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL NEUROSURGERY SURGICAL POWER TOOLS MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL NEUROSURGERY SURGICAL POWER TOOLS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL NEUROSURGERY SURGICAL POWER TOOLS MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL NEUROSURGERY SURGICAL POWER TOOLS MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL NEUROSURGERY SURGICAL POWER TOOLS MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL NEUROSURGERY SURGICAL POWER TOOLS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 46. AMERICAS NEUROSURGERY SURGICAL POWER TOOLS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 47. AMERICAS NEUROSURGERY SURGICAL POWER TOOLS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 48. AMERICAS NEUROSURGERY SURGICAL POWER TOOLS MARKET SIZE, BY POWER SOURCE, 2018-2032 (USD MILLION)
  • TABLE 49. AMERICAS NEUROSURGERY SURGICAL POWER TOOLS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 50. AMERICAS NEUROSURGERY SURGICAL POWER TOOLS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 51. NORTH AMERICA NEUROSURGERY SURGICAL POWER TOOLS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. NORTH AMERICA NEUROSURGERY SURGICAL POWER TOOLS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 53. NORTH AMERICA NEUROSURGERY SURGICAL POWER TOOLS MARKET SIZE, BY POWER SOURCE, 2018-2032 (USD MILLION)
  • TABLE 54. NORTH AMERICA NEUROSURGERY SURGICAL POWER TOOLS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 55. NORTH AMERICA NEUROSURGERY SURGICAL POWER TOOLS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 56. LATIN AMERICA NEUROSURGERY SURGICAL POWER TOOLS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. LATIN AMERICA NEUROSURGERY SURGICAL POWER TOOLS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 58. LATIN AMERICA NEUROSURGERY SURGICAL POWER TOOLS MARKET SIZE, BY POWER SOURCE, 2018-2032 (USD MILLION)
  • TABLE 59. LATIN AMERICA NEUROSURGERY SURGICAL POWER TOOLS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 60. LATIN AMERICA NEUROSURGERY SURGICAL POWER TOOLS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 61. EUROPE, MIDDLE EAST & AFRICA NEUROSURGERY SURGICAL POWER TOOLS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 62. EUROPE, MIDDLE EAST & AFRICA NEUROSURGERY SURGICAL POWER TOOLS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 63. EUROPE, MIDDLE EAST & AFRICA NEUROSURGERY SURGICAL POWER TOOLS MARKET SIZE, BY POWER SOURCE, 2018-2032 (USD MILLION)
  • TABLE 64. EUROPE, MIDDLE EAST & AFRICA NEUROSURGERY SURGICAL POWER TOOLS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 65. EUROPE, MIDDLE EAST & AFRICA NEUROSURGERY SURGICAL POWER TOOLS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 66. EUROPE NEUROSURGERY SURGICAL POWER TOOLS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. EUROPE NEUROSURGERY SURGICAL POWER TOOLS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 68. EUROPE NEUROSURGERY SURGICAL POWER TOOLS MARKET SIZE, BY POWER SOURCE, 2018-2032 (USD MILLION)
  • TABLE 69. EUROPE NEUROSURGERY SURGICAL POWER TOOLS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 70. EUROPE NEUROSURGERY SURGICAL POWER TOOLS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 71. MIDDLE EAST NEUROSURGERY SURGICAL POWER TOOLS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. MIDDLE EAST NEUROSURGERY SURGICAL POWER TOOLS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 73. MIDDLE EAST NEUROSURGERY SURGICAL POWER TOOLS MARKET SIZE, BY POWER SOURCE, 2018-2032 (USD MILLION)
  • TABLE 74. MIDDLE EAST NEUROSURGERY SURGICAL POWER TOOLS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 75. MIDDLE EAST NEUROSURGERY SURGICAL POWER TOOLS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 76. AFRICA NEUROSURGERY SURGICAL POWER TOOLS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 77. AFRICA NEUROSURGERY SURGICAL POWER TOOLS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 78. AFRICA NEUROSURGERY SURGICAL POWER TOOLS MARKET SIZE, BY POWER SOURCE, 2018-2032 (USD MILLION)
  • TABLE 79. AFRICA NEUROSURGERY SURGICAL POWER TOOLS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 80. AFRICA NEUROSURGERY SURGICAL POWER TOOLS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 81. ASIA-PACIFIC NEUROSURGERY SURGICAL POWER TOOLS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 82. ASIA-PACIFIC NEUROSURGERY SURGICAL POWER TOOLS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 83. ASIA-PACIFIC NEUROSURGERY SURGICAL POWER TOOLS MARKET SIZE, BY POWER SOURCE, 2018-2032 (USD MILLION)
  • TABLE 84. ASIA-PACIFIC NEUROSURGERY SURGICAL POWER TOOLS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 85. ASIA-PACIFIC NEUROSURGERY SURGICAL POWER TOOLS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL NEUROSURGERY SURGICAL POWER TOOLS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 87. ASEAN NEUROSURGERY SURGICAL POWER TOOLS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 88. ASEAN NEUROSURGERY SURGICAL POWER TOOLS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 89. ASEAN NEUROSURGERY SURGICAL POWER TOOLS MARKET SIZE, BY POWER SOURCE, 2018-2032 (USD MILLION)
  • TABLE 90. ASEAN NEUROSURGERY SURGICAL POWER TOOLS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 91. ASEAN NEUROSURGERY SURGICAL POWER TOOLS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 92. GCC NEUROSURGERY SURGICAL POWER TOOLS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 93. GCC NEUROSURGERY SURGICAL POWER TOOLS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 94. GCC NEUROSURGERY SURGICAL POWER TOOLS MARKET SIZE, BY POWER SOURCE, 2018-2032 (USD MILLION)
  • TABLE 95. GCC NEUROSURGERY SURGICAL POWER TOOLS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 96. GCC NEUROSURGERY SURGICAL POWER TOOLS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 97. EUROPEAN UNION NEUROSURGERY SURGICAL POWER TOOLS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 98. EUROPEAN UNION NEUROSURGERY SURGICAL POWER TOOLS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 99. EUROPEAN UNION NEUROSURGERY SURGICAL POWER TOOLS MARKET SIZE, BY POWER SOURCE, 2018-2032 (USD MILLION)
  • TABLE 100. EUROPEAN UNION NEUROSURGERY SURGICAL POWER TOOLS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 101. EUROPEAN UNION NEUROSURGERY SURGICAL POWER TOOLS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 102. BRICS NEUROSURGERY SURGICAL POWER TOOLS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 103. BRICS NEUROSURGERY SURGICAL POWER TOOLS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 104. BRICS NEUROSURGERY SURGICAL POWER TOOLS MARKET SIZE, BY POWER SOURCE, 2018-2032 (USD MILLION)
  • TABLE 105. BRICS NEUROSURGERY SURGICAL POWER TOOLS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 106. BRICS NEUROSURGERY SURGICAL POWER TOOLS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 107. G7 NEUROSURGERY SURGICAL POWER TOOLS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 108. G7 NEUROSURGERY SURGICAL POWER TOOLS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 109. G7 NEUROSURGERY SURGICAL POWER TOOLS MARKET SIZE, BY POWER SOURCE, 2018-2032 (USD MILLION)
  • TABLE 110. G7 NEUROSURGERY SURGICAL POWER TOOLS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 111. G7 NEUROSURGERY SURGICAL POWER TOOLS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 112. NATO NEUROSURGERY SURGICAL POWER TOOLS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 113. NATO NEUROSURGERY SURGICAL POWER TOOLS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 114. NATO NEUROSURGERY SURGICAL POWER TOOLS MARKET SIZE, BY POWER SOURCE, 2018-2032 (USD MILLION)
  • TABLE 115. NATO NEUROSURGERY SURGICAL POWER TOOLS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 116. NATO NEUROSURGERY SURGICAL POWER TOOLS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 117. GLOBAL NEUROSURGERY SURGICAL POWER TOOLS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 118. UNITED STATES NEUROSURGERY SURGICAL POWER TOOLS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 119. UNITED STATES NEUROSURGERY SURGICAL POWER TOOLS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 120. UNITED STATES NEUROSURGERY SURGICAL POWER TOOLS MARKET SIZE, BY POWER SOURCE, 2018-2032 (USD MILLION)
  • TABLE 121. UNITED STATES NEUROSURGERY SURGICAL POWER TOOLS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 122. UNITED STATES NEUROSURGERY SURGICAL POWER TOOLS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 123. CHINA NEUROSURGERY SURGICAL POWER TOOLS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 124. CHINA NEUROSURGERY SURGICAL POWER TOOLS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 125. CHINA NEUROSURGERY SURGICAL POWER TOOLS MARKET SIZE, BY POWER SOURCE, 2018-2032 (USD MILLION)
  • TABLE 126. CHINA NEUROSURGERY SURGICAL POWER TOOLS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 127. CHINA NEUROSURGERY SURGICAL POWER TOOLS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)